Official Title
Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients : ProCOVRA
Brief Summary

COVID-19 is an infectious disease caused by SARS-CoV2 virus. The objective of our study is to analyze the progression and the severity of COVID-19 in patients with RA. Indeed, few data are available on this subject, and this would allow us to improve management of COVID-19 in these potential at-risk patients.

Status
Completed
Conditions
COVID19
Rheumatoid Arthritis
Eligibility Criteria

Inclusion criteria:

- Confirmed COVID-19 diagnosis (positive PCR or serology) in RA patients or healthy
controls.

Exclusion criteria:

- Age under 18 years old

- Suspected COVID-19 diagnosis (typical symptoms without a positive PCR or serology)

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

UH Montpellier
Montpellier, France

Investigators

Padern Guillaume, physician, Principal Investigator
University Hospitals of Montpellier

Sponsors / Collaborators
University Hospital, Montpellier
NCT Number
NCT04679272
Keywords
DMARDs
Biotherapy
MeSH Terms
COVID-19
Arthritis
Arthritis, Rheumatoid